Considerations of expanded carrier screening: Lessons learned from combined malonic and methylmalonic aciduria
Abstract Background Expanded carrier screening (ECS) utilizes high‐throughput next‐generation sequencing to evaluate an individual's carrier status for multiple conditions. Combined malonic and methylmalonic aciduria (CMAMMA) due to ACSF3 deficiency is a rare inherited disease included in such...
Main Authors: | Marie Cosette Gabriel, Stephanie M. Rice, Jennifer L. Sloan, Matthew H. Mossayebi, Charles P. Venditti, Huda B. Al‐Kouatly |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-04-01
|
Series: | Molecular Genetics & Genomic Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/mgg3.1621 |
Similar Items
-
Brain metabolism and neurological symptoms in combined malonic and methylmalonic aciduria
by: Sara Tucci
Published: (2020-01-01) -
Current Updates on Expanded Carrier Screening: New Insights in the Omics Era
by: Iolanda Veneruso, et al.
Published: (2022-03-01) -
Management considerations for clinically relevant findings on expanded carrier screening in a sperm donor applicant population
by: Lauren Isley, M.S., C.G.C., et al.
Published: (2023-12-01) -
Clinical application value of expanded carrier screening in the population of childbearing age
by: Yuqin Fang, et al.
Published: (2023-04-01) -
Beyond the “Jewish panel”: the importance of offering expanded carrier screening to the Ashkenazi Jewish population
by: Shelley Dolitsky, M.D., et al.
Published: (2020-12-01)